A case for Tamoxifen with ovarian function suppression
Sign Up to like & getrecommendations! Published in 2020 at "Breast Cancer Research and Treatment"
DOI: 10.1007/s10549-020-05766-4
Abstract: Adjuvant endocrine treatment for premenopausal hormone receptor-positive breast cancer has become increasingly nuanced. Sufficient evidence and thus consensus exists on the treatment of patients at both ends of the spectrum; the lowest risk have excellent… read more here.
Keywords: tamoxifen ovarian; function suppression; case tamoxifen; ovarian function ... See more keywords